Granahan Investment Management Inc. MA increased its holdings in MINDBODY Inc (NASDAQ:MB) by 13.3% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 446,766 shares of the technology company’s stock after acquiring an additional 52,521 shares during the period. MINDBODY comprises approximately 1.0% of Granahan Investment Management Inc. MA’s portfolio, making the stock its 29th biggest holding. Granahan Investment Management Inc. MA owned about 0.96% of MINDBODY worth $11,549,000 at the end of the most recent quarter.

Several other hedge funds have also added to or reduced their stakes in the company. FMR LLC grew its holdings in shares of MINDBODY by 481.5% in the second quarter. FMR LLC now owns 3,150,890 shares of the technology company’s stock valued at $85,705,000 after acquiring an additional 2,609,059 shares in the last quarter. Capital World Investors grew its holdings in MINDBODY by 14.7% during the second quarter. Capital World Investors now owns 2,593,000 shares of the technology company’s stock valued at $70,530,000 after purchasing an additional 333,000 shares during the period. Vanguard Group Inc. grew its holdings in MINDBODY by 67.2% during the second quarter. Vanguard Group Inc. now owns 1,511,343 shares of the technology company’s stock valued at $41,109,000 after purchasing an additional 607,182 shares during the period. Victory Capital Management Inc. grew its holdings in MINDBODY by 4.5% during the third quarter. Victory Capital Management Inc. now owns 1,441,696 shares of the technology company’s stock valued at $37,268,000 after purchasing an additional 61,950 shares during the period. Finally, Renaissance Technologies LLC grew its holdings in MINDBODY by 44.2% during the second quarter. Renaissance Technologies LLC now owns 1,110,900 shares of the technology company’s stock valued at $30,216,000 after purchasing an additional 340,300 shares during the period. 90.16% of the stock is owned by institutional investors.

Shares of MINDBODY Inc (MB) opened at $30.65 on Monday. MINDBODY Inc has a 12-month low of $19.65 and a 12-month high of $36.25. The company has a current ratio of 9.20, a quick ratio of 9.20 and a debt-to-equity ratio of 0.06.

MINDBODY (NASDAQ:MB) last posted its earnings results on Thursday, October 26th. The technology company reported $0.01 earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.04) by $0.05. The firm had revenue of $46.60 million for the quarter, compared to the consensus estimate of $45.59 million. MINDBODY had a negative return on equity of 8.39% and a negative net margin of 9.26%. The business’s quarterly revenue was up 32.0% on a year-over-year basis. During the same quarter in the prior year, the business posted ($0.09) earnings per share. sell-side analysts predict that MINDBODY Inc will post -0.31 earnings per share for the current year.

In related news, CEO Richard Lee Stollmeyer sold 17,739 shares of the stock in a transaction on Friday, December 1st. The stock was sold at an average price of $31.95, for a total value of $566,761.05. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, CFO Brett T. White sold 10,000 shares of the stock in a transaction on Monday, October 2nd. The stock was sold at an average price of $26.56, for a total value of $265,600.00. The disclosure for this sale can be found here. In the last 90 days, insiders have acquired 955,594 shares of company stock worth $25,273,140 and have sold 178,717 shares worth $5,260,296. Corporate insiders own 8.22% of the company’s stock.

Several equities analysts have weighed in on MB shares. UBS reissued a “buy” rating and set a $40.00 price objective (up from $34.00) on shares of MINDBODY in a report on Thursday, November 9th. Roth Capital reissued a “buy” rating and set a $31.50 price objective on shares of MINDBODY in a report on Thursday, September 28th. Zacks Investment Research lowered MINDBODY from a “buy” rating to a “hold” rating in a report on Wednesday, November 1st. BidaskClub raised MINDBODY from a “hold” rating to a “buy” rating in a report on Friday, September 8th. Finally, KeyCorp raised MINDBODY from a “sector weight” rating to an “overweight” rating and increased their price objective for the company from $16.95 to $32.00 in a report on Friday, September 22nd. Three investment analysts have rated the stock with a hold rating and ten have given a buy rating to the stock. MINDBODY has a consensus rating of “Buy” and an average price target of $32.54.

COPYRIGHT VIOLATION WARNING: “MINDBODY Inc (MB) Stake Boosted by Granahan Investment Management Inc. MA” was first reported by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are viewing this piece on another website, it was stolen and reposted in violation of US and international copyright legislation. The legal version of this piece can be accessed at https://www.thecerbatgem.com/2017/12/11/mindbody-inc-mb-stake-boosted-by-granahan-investment-management-inc-ma.html.

About MINDBODY

MINDBODY, Inc is a provider of cloud-based business management software for the wellness services industry and operates as a consumer marketplace with local business subscribers on its platform. The Company’s subscribers provide a range of wellness services to active consumers. Its integrated software and payments platform helps business owners in the wellness services industry run, market and build their businesses.

Want to see what other hedge funds are holding MB? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MINDBODY Inc (NASDAQ:MB).

Institutional Ownership by Quarter for MINDBODY (NASDAQ:MB)

Receive News & Stock Ratings for MINDBODY Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MINDBODY Inc and related stocks with our FREE daily email newsletter.